In:
British Journal of Ophthalmology, BMJ, Vol. 103, No. 5 ( 2019-05), p. 610-616
Abstract:
To systematically compare the intermodality and inter-reader agreement for two blue-light confocal fundus autofluorescence (FAF) systems. Methods Thirty eyes (21 patients) with a diagnosis of geographic atrophy (GA) were enrolled. Eyes were imaged using two confocal blue-light FAF devices: (1) Spectralis device with a 488 nm excitation wavelength (488-FAF); (2) EIDON device with 450 nm excitation wavelength and the capability for ‘colour’ FAF imaging including both the individual red and green components of the emission spectrum. Furthermore, a third imaging modality (450-RF image) isolating and highlighting the red emission fluorescence component (REFC) was obtained and graded. Each image was graded by two readers to assess inter-reader variability and a single image for each modality was used to assess the intermodality variability. Results The 95% coefficient of repeatability (1.35 mm 2 for the 488-FAF-based grading, 8.13 mm 2 for the 450-FAF-based grading and 1.08 mm 2 for the 450-RF-based grading), the coefficient of variation (1.11 for 488-FAF, 2.05 for 450-FAF, 0.92 for 450-RF) and the intraclass correlation coefficient (0.994 for 488-FAF, 0.711 for 450-FAF, 0.997 for 450-RF) indicated that 450-FAF-based and 450-RF-based grading have the lowest and highest inter-reader agreements, respectively. The GA area was larger for 488-FAF images (median (IQR) 2.1 mm 2 (0.8–6.4 mm 2 )) than for 450-FAF images (median (IQR) 1.0 mm 2 (0.3–4.3 mm 2 ); p 〈 0.0001). There was no significant difference in lesion area measurement between 488-FAF-based and 450-RF-based grading (median (IQR) 2.6 mm 2 (0.8–6.8 mm 2 ); p=1.0). Conclusion The isolation of the REFC from the 450-FAF images allowed for a reproducible quantification of GA. This assessment had good comparability with that obtained with 488-FAF images.
Type of Medium:
Online Resource
ISSN:
0007-1161
,
1468-2079
DOI:
10.1136/bjophthalmol-2018-311849
DOI:
10.1136/bjophthalmol-2018-311849.supp1
DOI:
10.1136/bjophthalmol-2018-311849.supp1
DOI:
10.1136/bjophthalmol-2018-311849.supp2
Language:
English
Publisher:
BMJ
Publication Date:
2019
detail.hit.zdb_id:
1482974-5